{
  "main_header": {
    "sid": 10039033,
    "name": "Valiant Laborato",
    "stock_name": "Valiant Laborato",
    "full_name": "Valiant Laboratories Ltd",
    "name_url": "stocks-analysis/valiant-laborato",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "56.18",
    "chg": -1.13,
    "chgp": "-1.97%",
    "dir": -1,
    "prev_price": "57.31",
    "mcapval": "309.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543998,
    "symbol": "VALIANTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0JWS01017",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "36.65 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/valiant-laborato-10039033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 263,
    "sid": "10039033",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/valiant-laboratories-10039033"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Closure of Trading Window for declaration of Financial Results for the quater and year ended 31 March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Feb-2026",
      "details": "Copy of Newspaper Publication of Financial Results for the Quarter and NIne Months ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
      "datetime": "11-Feb-2026",
      "details": "Monitoring Agency Report for the quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News